Blog Voices from the Frontlines
Americans for Safe Access Urges Members of Congress to Stop Using False Information About Marijuana
Washington, DC — Today, Americans for Safe Access, a national nonprofit dedicated to ensuring safe and legal access to medical cannabis for therapeutic use and research, sent a memo to Congress informing members that the Drug Enforcement Administration (DEA) has removed false information about cannabis from its website after months of public pressure. The memo explains;
Forty-four states now allow patients under their physician's care to use medical cannabis (marijuana) in some form, and the majority of the rest of the states are discussing medical cannabis in their current legislative sessions. In addition, three cannabis related budget amendments and four bills have been introduced so far in the 115th Congress.
We know that you rely on the Drug Enforcement Administration (DEA) to provide current and accurate information when you are making decisions about cannabis policy. Americans for Safe Access (ASA) has prepared this memo to inform you about four important changes in the DEA’s positions on medical cannabis that could have an impact on your policy making decisions this session.
View the memo here: http://www.safeaccessnow.org/iqa_memo
By Vince Sliwoski for the Portland Mercury
Was the DEA forced to remove “alternative facts” about cannabis from its website?
YES! IN DECEMBER, the medical marijuana advocacy group, Americans for Safe Access (ASA), formally requested that the federal Drug Enforcement Agency (DEA) remove or correct a cluster of misinformation on medical cannabis from its website. Shortly thereafter, DEA complied.
By Christine Vestal for the Huffington Post
Enacted in 2014, New York’s medical marijuana law is considered among the most cautious in the nation. Americans for Safe Access, a patient advocacy group, gives the state a letter grade of C when it comes to balancing product safety and ease of access to the emerging medicine.
By Aaron G. Biros for the Cannabis Industry Journal
Members of Congress last week announced the formation of a ‘Congressional Cannabis Caucus’ in order to organize and affect cannabis policy at the federal level. Representatives Earl Blumenauer (D-OR), Dana Rohrabacher (R-CA), Jared Polis (D-CO) and Don Young (R-AK) announced the creation of the caucus on February 16th. Cannabis advocacy and drug policy groups were quick to commend the formation of the organization.
In a joint statement issued on Friday, the National Cannabis Industry Association, the Marijuana Policy Project, the Drug Policy Alliance, NORML, Americans for Safe Access, Students for Sensible Drug Policy, Law Enforcement Action Partnership, Doctors for Cannabis Regulation, and Clergy for a New Drug Policy expressed commendation and excitement for the new group. “We commend Representatives Blumenauer, Rohrabacher, Polis, and Young for their leadership on the issue of cannabis policy,” reads the statement. “The establishment of a Cannabis Caucus will allow members from both parties, who represent diverse constituencies from around the country, to join together for the purpose of advancing sensible cannabis policy reform. It will also facilitate efforts to ease the tension between federal prohibition laws and state laws that regulate cannabis for medical and adult use.”
By Winnie Hu for The New York Times
While there is no shortage of research on marijuana, relatively little of it has focused explicitly on older users even as their numbers grow — and not just in the United States. In Israel, for instance, older people have been treated with medical marijuana for years. And Americans for Safe Access, an advocacy group, helped open a research center in the Czech Republic that is evaluating its impact on older people.
Cannabis, Drug Policy Reform Advocates Commend Congressional Members on Formation of Congressional Cannabis Caucus - Americans for Safe Access
WASHINGTON, DC, Feb. 16, 2017— Joint statement below from The National Organization For the Reform of Marijuana Laws (NORML), the Drug Policy Alliance, Students for Sensible Drug Policy, Americans for Safe Access, Marijuana Policy Project, the National Cannabis Industry Association, Law Enforcement Action Partnership, Doctors for Cannabis Regulation, and Clergy for a New Drug Policy.
By Sari Staver for The Bay Area Reporter
"Dennis is one of my heroes, he has been a guiding light in the medical marijuana movement and many of us have counted on him to lead the way." - Brent Saupe, who worked with Dennis Peron as an ASA volunteer
Government has apparently dropped 'gateway' theory, marijuana critics should too - Americans for Safe Access
Steph Sherer calls on politicians to stop basing policy on outdated cannabis myths that the DEA has disavowed.
Read more on The Hill.
By Mike Adams for Merry Jane
Agency now admits weed doesn’t cause cancer or psychosis.
Although the U.S. Drug Enforcement Administration (DEA) has all but refused to consider the cannabis plant as having any medicinal application within the confines of the Controlled Substances Act, the nation’s leading drug sniffing hounds recently eliminated some misinformation about the potential dangers of the herb from the its website.
The update to the agency’s digital presence was made after Americans for Safe Access, a nonprofit advocacy group fighting for marijuana to be recognized for its medicinal function, filed a petition with the higher ups at the U.S. Department of Justice demanding the DEA eliminate inaccurate language from its marijuana-related material.
By Lisa Rough for Leafly
As the ASA notes in its letter, now is a particularly crucial time to ensure that all information being disseminated from the government be factually accurate. President Trump’s newly appointed attorney general, former Alabama Sen. Jeff Sessions, has made it clear in past statements that he opposes cannabis use, and some are concerned the White House’s looseness with the truth could creep into federal drug policy and put patients at risk.